ROCHE_WEB THUMBNAIL
April 16, 2024

Faricimab – The Fight Against Retinal Diseases

Faricimab (Vabysmo) is the first approved bispecific antibody uniquely engineered to block two key pathways driving retinal vascular disease by…

popular posts
Article 1 Day 1_ ARVO
May 6, 2025

Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work

latest posts
Article 1 Day 1_ ARVO
May 6, 2025

Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work

unnamed (22)
April 16, 2025

FDA Grants RMAT Designation to Atsena Therapeutics’ Gene Therapy for X-linked Retinoschisis

ROCHE_WEB THUMBNAIL
April 16, 2024

Faricimab – The Fight Against Retinal Diseases

anclro_3D_illustration_of_a_retina_in_shiny_plastic_finish_5cee1144 5d20 4883 afd8 0ce639b5ae81
February 28, 2024

Innovations in Sight

Thumnail_ Topcon 01
November 27, 2023

Topcon Introduces NW500 at EURETINA 2023

COVER ART TOC
November 17, 2023

A REVOLUTION in Retinal Therapies: From anti-VEGF to TKIs and gene therapy, cutting-edge innovations are changing the landscape of medical retina

img728
October 7, 2023

Going Hybrid: Could combination therapy be the solution for patients with anti-VEGF-resistant AMD?

shutterstock_1675947649
October 7, 2023

Our AI Allies: 4 Reasons why artificial intelligence is important in medical image analysis

Discover our fascinating content at issuu

explore